Reto Andreas Gadient
- Camino Pharma, LLC (no department on record)
From the FY2024 NIH awards this investigator leads as contact PI. The department is the award's.
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 12519677Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 onlyCareer claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2024
Award data coverage
ScienceDex currently has one fiscal year of PI ranking data for this record. This does not establish the first NIH award or current employer.
Single fiscal year on record (FY2024): $994.9K in linked award amounts across 1 award record · Award-linked rank #15204.
FY2024 award records by amount
NIH award records listing Reto Andreas Gadient as a PI. Multi-PI records show the full award amount for context.
- 5U43AA031388-02U43Contact PIPreclinical validation of mGlu2 PAMs in alcohol use disorder$994.9Kaward amount
Award organization
Organizations that administered FY2024 awards listing Reto Andreas Gadient as a PI.
FY2024 award administered by Camino Pharma, LLC (CA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardCamino Pharma, LLC
- 2024$500K Cumulative Funding
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Reto Andreas Gadient.